Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

J B Chemicals and Pharmaceuticals Ltd

JBCHEPHARM.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Mid Cap Analyst: N/A

Last Close

$25.00

▲ +0.00%

Market Cap $4.02B · Vol 4.78M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$4.02B

Mid Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

65.89

Momentum

Beta

0.26

vs Market

52W High

$26.19

4.62% below

52W Low

$16.99

35.29% above

Volume

4.78M

Avg 492.52K

P/B

7.97

Price-to-book

ROE

19.40%

Return on equity

Free Float

50.78%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does JBCHEPHARM.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-1.09%

+9.71%

+20.57%

+26.52%

YTD

+32.38%

+44.76%

+55.46%

+154.61%

Financials & Valuation

TTM · Annual

Total Revenue	$443.82M
Net Income	$75.91M
Revenue Growth (YoY)	-4.77%
Gross Margin	61.65%
Operating Margin	22.26%
Net Profit Margin	17.10%
ROE	19.40%
ROA · ROIC	20.61% · 18.71%

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	6.69
P/S	7.94
P/B	7.97
P/FCF	52.52
EPS Growth	N/A
Outstanding Shares	160.56M

Technical Indicators

50-Day SMA	$23.30
200-Day SMA	$20.42
RSI (14)	65.89
Beta	0.26
52-Week High	$26.19
52-Week Low	$16.99

Volume Today	4.78M
Avg Daily Volume (30D)	492.52K
Relative Volume	9.70x
Volatility (10D)	23.22
Volatility (30D)	19.70
Free Float	50.78%

Analyst Consensus

N/A

Current Price $25.00

Mean Target N/A

52W Low$16.99 52W High$26.19

Current

Target

$16.99 $26.19

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S83QF2

ISININE572A01036

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

J.B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The Company specializes in gastroenterology, hypertension and dermatology. It is also focused on other therapeutic categories like nephrology, respiratory, virology, diabetes, and nicotine replacement therapy (NRT). The Company is engaged in the business of manufacturing and marketing of a diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). Its brands include Nicardia, Cilacar, Rantac, Metrogyl, and Cilacar-T. It specializes in manufacturing medicated and herbal lozenges. It produces hard-candy lozenges, soft-center lozenges and powder-filled lozenges for varied medical needs. Its API products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Nifedipine, and others. It maintains a direct presence in Russia and South Africa, while leveraging distributor partnerships across the United States, Asia, Africa, and Latin America.